Identification of variant of insulin receptor gene in resistant diabetes
Nội dung chính của bài viết
Tóm tắt
Insulin resistance is defined as a reduced biological response of target tissues to normal insulin levels and is a major mechanism leading to type 2 diabetes, particularly in obese individuals. Beyond obesity, other causes include medications (e.g., glucocorticoids, antiretrovirals, oral contraceptives), stress, pregnancy, dyslipidemia, insulin receptor autoantibodies (Type B insulin resistance), and genetic defects. Among genetic causes, mutations in the insulin receptor (INSR) gene can lead to severe insulin resistance known as Type A insulin resistance. This rare inherited disorder belongs to a spectrum of monogenic insulin resistance syndromes, including Donohue and Rabson-Mendenhall syndromes. We report a 12-year-old boy with diabetes due to an INSR mutation. He presented with polyuria, polydipsia, and weight loss. His height was 142cm (0 SD), and BMI decreased from 23.3 to 21.3 kg/m² (> 95th percentile). No acanthosis nigricans was observed. Lab results showed fasting glucose 16.8 mmol/L, HbA1c 7.8%, and HOMA-IR 11.2. Genetic testing revealed a novel heterozygous variant c.4115G>A (p.Arg1372Gln) of INSR gene; the mother carried the same variant, while the father was wild type. The patient responded well to lifestyle modification, insulin, and metformin therapy.
Chi tiết bài viết
Từ khóa
Diabetes in children, insulin resistance, INSR
Tài liệu tham khảo
2. Kahn CR, Flier JS, Bar RS, et al. The Syndromes of Insulin Resistance and Acanthosis Nigricans: Insulin-Receptor Disorders in Man. N Engl J Med. 1976;294(14):739-745. doi:10.1056/NEJM197604012941401
3. Hosoe J, Kadowaki H, Miya F, et al. Structural Basis and Genotype–Phenotype Correlations of INSR Mutations Causing Severe Insulin Resistance. Diabetes. 2017;66(10):2713-2723. doi:10.2337/db17-03 01
4. De Meyts P, Whittaker J. Structural biology of insulin and IGF1 receptors: implications for drug design. Nat Rev Drug Discov. 2002;1(10):769-783. doi:10.1038/nrd917
5. Huang Z, Li Y, Tang T, et al. Hyperinsulinaemic hypoglycaemia associated with a heterozygous missense mutation of R1174W in the insulin receptor (IR) gene. Clinical Endocrinology. 2009;71(5):659-665. doi:10.1111/j.1365-2265.2009.03525.x
6. De Meyts. Insulin and its receptor: structure, function and evolution. BioEssays. 2004;26(12). Accessed April 13, 2025. https://onlinelibrary.wiley.com/doi/abs/10.1002/bies.20151
7. Yoshimasa Y, Seino S, Whittaker J, et al. Insulin-Resistant Diabetes Due to a Point Mutation That Prevents Insulin Proreceptor Processing. Science. 1988;240(4853):784-787. doi:10.1126/science.3283938
8. Taylor SI, Cama A, Accili D, et al. GENETIC BASIS OF ENDOCRINE DISEASE 1 Molecular Genetics of Insulin Resistant Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism. 1991;73(6):1158-1163. doi:10.1210/jcem-73-6-1158
9. Kelsey MM, Zeitler PS. Insulin Resistance of Puberty. Curr Diab Rep. 2016;16(7):64. doi:10.1007/s11892-016-0751-5
10. O Ardon, M Procter, T Tvrdik, et al. Sequencing analysis of insulin receptor defects and detection of two novel mutations in INSR gene. Mol Genet Metab Rep. 2014;1:71-84.
11. Robert K Semple, David B Savage, Elaine K, et al. Cochran Genetic Syndromes of Severe Insulin Resistance. Endocrine Reviews. 2011;32(4):498-514.
12. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proceedings of the National Academy of Sciences. 2007;104(43):17040-17045. doi:10.1073/pnas.0705894104
13. Hubbard SR. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. The EMBO Journal. 1997;16(18):5572-5581. doi:10.1093/emboj/16.18.5572
14. Gianni MDG, Paul GD, Patricia CB, et al. Insulin receptor internalization and signaling. Molecular and Cellular Biochemistry. 1998;182(1-2):59-63.